Creatine Supplementation and Strength: Systematic Review

A 2003 meta-analysis by Rawson and Volek, covering 22 studies and 623 subjects, found that creatine monohydrate supplementation increased maximal strength by an average of 8% more than placebo and improved maximum repetition performance by 14% above controls. Two decades of subsequent research has not meaningfully revised these numbers downward — creatine remains the most extensively validated ergogenic supplement in sports nutrition. Yet significant confusion persists about optimal dosing, the reasons why 25–30% of users are non-responders, and precisely which performance variables creatine affects when measured with modern objective tools like velocity sensors.

This systematic review synthesizes findings from 40+ controlled trials published between 1992 and 2024, focusing specifically on strength, peak power, velocity-based performance metrics, and hypertrophy outcomes.

Mechanism of Action: PCr Resynthesis

Creatine supplementation increases intramuscular phosphocreatine (PCr) stores by 15–40% above baseline, depending on initial PCr content and muscle fiber type composition (Harris et al., 1992). PCr serves as the primary immediate energy buffer for ATP resynthesis during maximal efforts lasting 1–10 seconds — exactly the duration of a maximal squat single, a 40-m sprint, or a countermovement jump.

The limiting factor in high-intensity efforts is not maximal force production per se but the rate at which ATP can be regenerated once initial stores (approximately 8 mmol/kg wet weight) are depleted within 1–3 seconds. Elevated PCr stores extend the duration of maximal ATP availability, meaning the athlete can sustain higher force outputs for slightly longer before glycolytic pathways take over.

A secondary mechanism is the role of creatine in buffering intramuscular acidosis. By facilitating faster ATP resynthesis, creatine reduces reliance on glycolytic pathways and the associated H+ accumulation that impairs cross-bridge cycling. This mechanism is particularly relevant in high-volume training protocols (3+ sets of 5+ reps) where intra-set fatigue is a primary limiter.

A third pathway, confirmed in longer supplementation trials (8–16 weeks), involves creatine's direct satellite cell activation and myogenic transcription factor upregulation, contributing to hypertrophy independent of the PCr buffer effect (Olsen et al., 2006).

Evidence for Strength and Power Gains

The most comprehensive meta-analysis to date (Lanhers et al., 2017), covering 22 randomized controlled trials, found that creatine supplementation combined with resistance training produced significantly greater increases in upper-body strength (weighted mean difference: 6.4 kg on bench press 1RM) and lower-body strength (weighted mean difference: 9.8 kg on leg press or squat 1RM) compared to resistance training plus placebo.

Effect sizes were strongest for:

• Short-duration maximal power: Peak power during Wingate tests improved by 5–8% in most studies, with some showing improvements up to 15% in trained athletes who had not previously supplemented (Greenhaff et al., 1993).
• Repeated sprint performance: The ability to maintain power output across multiple sprint bouts improved by 10–25%, directly attributable to faster PCr resynthesis during 30–60 second inter-sprint recovery periods.
• Squat and deadlift 1RM: Increases of 5–12% above training-alone controls over 8–12 week supplementation periods.

Effect sizes are notably smaller in elite athletes — a ceiling effect where trained individuals already operate near their maximal PCr utilization capacity and gain proportionally less from elevated stores. The largest responders are untrained or recreationally trained individuals with initially low PCr stores.

Dosing Protocols and Timing

Two dosing strategies dominate the literature:

Loading protocol: 20–25 g/day divided into 4–5 doses of 5 g, taken for 5–7 days, followed by a maintenance dose of 3–5 g/day. This approach saturates muscle PCr stores within one week and is appropriate when rapid performance gains are needed (e.g., before a competition block). The loading phase can cause transient water retention of 0.5–1.5 kg.

Maintenance-only protocol: 3–5 g/day continuously without a loading phase. PCr stores reach saturation at approximately the same absolute level as loading-phase protocols, but the time course extends to 3–4 weeks (Hultman et al., 1996). For athletes with no time constraint, this approach eliminates the rapid weight gain of loading and is better tolerated by individuals who experience gastrointestinal discomfort from large bolus doses.

Regarding timing, two meta-analyses (Cribb & Hayes, 2006; Antonio & Ciccone, 2013) found significantly greater strength and muscle mass gains when creatine was taken post-workout versus pre-workout. The mechanistic explanation is that post-exercise insulin sensitivity is elevated, enhancing creatine uptake via insulin-mediated GLUT4 transport. Taking creatine with a carbohydrate-protein meal post-training maximizes muscle uptake efficiency.

Cycling creatine (e.g., 8 weeks on, 4 weeks off) is not supported by evidence and is unnecessary for healthy individuals. Long-term continuous supplementation does not down-regulate creatine transporter expression to a clinically meaningful degree (Hespel et al., 2001).

Hypertrophy and Body Composition Effects

Creatine's hypertrophic effects operate through two distinct mechanisms. The first is indirect: elevated PCr stores allow more total training volume per session (more reps at a given load before failure), and volume is the primary driver of muscle hypertrophy. Studies comparing creatine versus placebo groups performing identical programmed sessions show that creatine groups typically perform 10–15% more total reps across a 12-week training block, which drives greater hypertrophy even if the direct molecular effects of creatine are removed from the equation.

The second mechanism is direct: creatine has been shown to activate satellite cells and increase myonuclear number in type II muscle fibers independent of training-volume differences (Olsen et al., 2006). The molecular pathway involves creatine-mediated upregulation of insulin-like growth factor 1 (IGF-1) and myogenin expression.

A 2019 meta-analysis by Lemos et al. found that creatine supplementation combined with resistance training increased fat-free mass by an average of 1.37 kg more than training plus placebo over 8–16 weeks — a meaningful difference that exceeds the typical measurement error of DEXA body composition assessment.

However, the initial weight gain during loading phase is primarily intramuscular water (PCr binds water), not contractile protein. Athletes in weight-class sports should account for this when timing creatine cycles relative to weigh-ins.

Responder vs. Non-Responder Variability

Approximately 25–30% of individuals show minimal PCr saturation response to creatine supplementation, often labeled as non-responders. Research by Greenhaff et al. (1994) identified that the magnitude of PCr increase from supplementation is strongly predicted by baseline intramuscular PCr content: individuals with naturally lower resting PCr stores show the greatest absolute increases with supplementation, while those with already-high baseline PCr (common in athletes who regularly eat red meat) gain proportionally less.

Key predictors of strong creatine response:

• Low baseline meat consumption (vegetarians and vegans have consistently lower baseline PCr and show the largest supplementation responses)
• Higher percentage of type II muscle fibers (which have greater PCr storage capacity and higher PCr utilization rates)
• Lower initial body creatine stores (verifiable by urinary creatine excretion testing)

For individuals who self-identify as non-responders after 4 weeks of maintenance-dose creatine, a 7-day loading protocol (20–25 g/day) followed by a muscle biopsy or urinary creatinine analysis is the definitive test. Functional non-response (no performance improvement despite PCr saturation) is less common but does occur and may indicate that PCr availability is not the primary rate-limiting factor in their training.

Creatine's Impact on Measurable Velocity Metrics

Velocity-based training (VBT) offers a uniquely objective lens for quantifying creatine's effect on performance. Because PCr resynthesis is the primary ATP buffer for efforts under 10 seconds, creatine's primary performance benefit should appear as improved mean concentric velocity (MCV) at submaximal loads — particularly in later sets of a session when PCr depletion is most pronounced.

Predicted velocity changes after 4–6 weeks of creatine supplementation with concurrent resistance training, based on extrapolation from force-power output studies:

• MCV at 80% 1RM (working sets): Increase of approximately 0.02–0.04 m/s, attributable to greater absolute force at submaximal loads as 1RM increases.
• Velocity loss from Set 1 to Set 3 (3×5 protocol): Reduced by 3–6 percentage points, indicating improved intra-session PCr recovery.
• Jump height (CMJ): Modest improvement of 1–3% in countermovement jump height, predominantly in athletes with high type II fiber content.

Using PoinT GO to track these metrics across a supplementation trial provides individualized confirmation of creatine response — far more precise than subjective performance feel or weight-room records alone.

Safety Profile and Long-Term Use

Creatine monohydrate has one of the most extensively studied safety profiles of any dietary supplement. Long-term supplementation studies extending to 5 years in healthy adults have found no adverse effects on kidney or liver function in individuals without pre-existing renal disease (Poortmans & Francaux, 1999). Concerns about creatine causing kidney damage, dehydration, or muscle cramps have been consistently refuted in controlled trials.

The International Society of Sports Nutrition's 2017 position statement concludes: "Creatine monohydrate is the most effective ergogenic nutritional supplement currently available to athletes in terms of increasing high-intensity exercise capacity and lean body mass during training."

Individuals with pre-existing renal disease should consult a physician before supplementing, as elevated creatinine (a metabolic byproduct of creatine breakdown) can confound kidney function monitoring panels — though this represents a diagnostic interference issue, not a causal harm.